TransMedics Group, Inc.
TMDX
$117.38
$2.201.91%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 9.64% | 18.02% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.64% | 18.02% | |||
| Cost of Revenue | 9.89% | 11.49% | |||
| Gross Profit | 9.48% | 22.52% | |||
| SG&A Expenses | 1.06% | -6.99% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.06% | 2.76% | |||
| Operating Income | 33.25% | 217.48% | |||
| Income Before Tax | 35.64% | 281.69% | |||
| Income Tax Expenses | 28.27% | 653.03% | |||
| Earnings from Continuing Operations | 35.92% | 274.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 35.92% | 274.54% | |||
| EBIT | 33.25% | 217.48% | |||
| EBITDA | 28.94% | 134.43% | |||
| EPS Basic | 35.15% | 273.15% | |||
| Normalized Basic EPS | 34.87% | 280.31% | |||
| EPS Diluted | 30.83% | 251.10% | |||
| Normalized Diluted EPS | 33.49% | 236.58% | |||
| Average Basic Shares Outstanding | 0.57% | 0.38% | |||
| Average Diluted Shares Outstanding | 1.61% | 13.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||